Bellicum pharmaceuticals to participate in the 2022 cell & gene meeting on the mesa

Houston, oct. 04, 2022 (globe newswire) -- bellicum pharmaceuticals, inc. (nasdaq: blcm), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that rick fair, president and ceo, will present at the annual cell & gene meeting on the mesa to be held october 11-13 in carlsbad, ca and livestreamed globally.
BLCM Ratings Summary
BLCM Quant Ranking